Exosome Therapy for Skin: What the Evidence Shows

Exosomes are extracellular vesicles — very small packages released by cells that carry proteins, lipids and genetic material such as messenger RNA. They are one of the ways cells communicate with each other.

The rationale in aesthetics is that if you deliver these signalling packages into skin, you can prompt the local cells to behave in a more regenerative way: increased collagen production, reduced inflammation, faster repair.

That is a reasonable hypothesis, and laboratory and early clinical work supports parts of it. The gap between that and the claims sometimes made in advertising is where patients should be careful.

In most aesthetic settings exosomes are applied topically immediately after microneedling. The microneedling creates controlled micro-channels, and the exosome preparation is applied so it can reach beyond the skin surface.

This has a consequence worth understanding: microneedling on its own stimulates collagen and improves skin. When a treatment combines the two, separating the effect of the exosomes from the effect of the needling is genuinely difficult, and much of the published work has this limitation.

Sessions take around an hour including numbing, with redness for one to three days afterwards, comparable to microneedling alone.

PRP is the closest established comparison, and patients frequently ask which to choose.

Being straightforward about this is more useful than enthusiasm.

There is credible laboratory evidence that exosomes influence cell behaviour in ways relevant to skin repair, and a growing number of small clinical studies reporting improvements in skin quality, redness and recovery after procedures. Patient satisfaction in practice is generally good.

The limitations are real. Study sizes are small, follow-up is short, many studies are industry-sponsored, and — importantly — exosome products are not standardised between manufacturers. Two products sold under the same category name may differ substantially in what they actually contain. Comparing results between studies, or between clinics, is therefore difficult.

It is fair to describe exosome therapy as promising and reasonable to offer, and unfair to describe it as proven superior to better-established options. Anyone presenting it as a breakthrough that outperforms everything else is ahead of the data.

This deserves a section of its own, because it is the part patients are least often told about and the part most likely to change.

Regulatory treatment of exosome products differs between jurisdictions, and the category has drawn scrutiny from regulators in several markets — including warnings in the United States about unapproved exosome products marketed for therapeutic use. Classification also depends on how a product is presented and administered.

This clinic confirms product details at consultation. Where we are uncertain about regulatory classification, we will tell you that rather than reassure you.

Exosome therapy is reasonable for people seeking a regenerative approach to skin quality, those wanting to support recovery after other procedures, and those exploring options for early hair thinning alongside established treatments.

It is worth considering alternatives first if:

• You want the best-evidenced regenerative option — PRP has a longer track record, particularly for hair.
• Your main concern is texture and elasticity — polynucleotide treatment has more published clinical use for that specific indication.
• Your main concern is dehydration and early laxity — Profhilo targets that directly.
• Cost is a deciding factor — exosome products are generally among the more expensive options; compare published pricing on the prices page.

It is not used during pregnancy or breastfeeding, where there is active infection in the treatment area, or where microneedling would otherwise be inappropriate. A full medical history is taken at consultation.